Scarletred wins international WSA YOUNG INNOVATORS 2017

WSA Young Innovators is a special recognition for young social entrepreneurs under 30 years of age, using ICTs to take action on the United Nations Sustainable Development Goals (UN SDGs). Together with the WSA winners of each year, they are honored as outstanding digital innovation with social impact.

From nearly 500 submissions, this years WSA Online Jury had a hard time to select the 5 winners of the WSA Young Innovators.

In a 2 phase online Jury process, 5 digital solutions of young innovators under the age of 30 were selected as the best practice examples for 2017.

Together with the 40 winners of WSA, the winners of the WSA Young Innovators will present their solution and get awarded at the WSA Global Congress in Vienna, Austria in March 20-22 2018.

The Winners 2017:

  • Erase All Kittens
  • giftedMom
  • OneLamp
  • oPerception
  • Scarletred(R)Vision

About WSA
The World Summit Awards are a unique awards system, selecting and promoting local digital innovation with high impact on improving society. Combining an ongoing  series of international events and activities with a global network of start-ups, social entrepreneurs, mentors, jurors, speakers, experts, government leaders, academia and civil society, WSA is an international platform for cut edge examples on how ICTs can have an impact on society.

Running 15 years by now, WSA has become a quality seal for digital content with societal impact in over 180 participating countries.

WSA keeps a close strategic association with the United Nation agendas. By reporting back national digital developments to the UN WSIS process it is supporting the UN Post-2015 Sustainable Development Agenda.


  •     Year: 2017
  •     Award: WSA Young Innovators
  •     Category: Innovation for SDGs
  •     Producer: Harald SCHNIDAR
  •     Organisation: SCARLETRED®Vision
  •     Country: Austria
  •     URL:

Scarletred®Vision is the first objective dermatologic image analysis platform, which runs mobile on smartphone and tablet technology and so everywhere in everybody’s pocket. It is the first multi component medical device system enabling objective visual assessment and analysis of dermatologic disease or skin drug effect independent of the user`s location. At the moment neither any medical device is known basing on a comparable technology nor harbours such advanced clinical development state and broad application scope. Due to its platform architecture it can be easily scaled up from local singe centric to global multi centric application.

The four main components of the Scarletred®Vision product:

(1) Scarletred®Mobile App: The mobile App is supplied on iOS (iPhone/iPad) and available free for download within the App store. It can be installed on an infinite number of devices and used for private, medical routine or clinical trial purpose. The App allows taking calibrated skin images and tagging of such images with a QR/Bar code when used in combination with the companion products 2 and 3.

(2) Scarletred®Skin patch: The patch is a novel gold standard for skin imaging and is detected automatically by the Scarletred®Vision mobile App. Co-imaging of the skin patch normalizes the generated images for differing light conditions and increases the quality of gained raw data significantly. It can be ordered online and is also planned being distributed OTC in pharmacy and cosmetics stores.

3) Scarletred®QR code: Subject QR code tagging enables fully automated data management and big-data application in clinical trial and routine. The encrypted codes can be generated within the Scarletred®Online platform and are supplied directly to the client. They assure highest data safety standards in clinical trials and allow reducing data management cost in clinical routine by more than 90%.

(4) Scarletred®Online platform: The online platform is the powerful core component of the system. It can be accessed by secured login via browser on any computer/smartphone/tablet. Clinically validated skin analysis algorithms are therein provided, enabling to measure e.g. changes in the skin erythema/pigmentation or in the size or shape of a mole or a healing wound over time.

Harald Schnidar,  PhD.  MBA
Email: harald.schnidar(at)

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)